The treatment of Raynaud's phenomenon. 1994

J R Seibold, and N E Allegar
Clinical Pharmacology Unit, UMDNJ-Robert Wood Johnson Medical School, New Brunswick 08903-0019.

UI MeSH Term Description Entries
D007650 Ketanserin A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione,R-41,468,R-41468,R 41,468,R 41468,R41,468,R41468
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001521 Behavior Therapy The application of modern theories of learning and conditioning in the treatment of behavior disorders. Behavior Change Techniques,Behavior Modification,Behavior Treatment,Conditioning Therapy,Therapy, Behavior,Therapy, Conditioning,Behavior Change Technique,Behavior Modifications,Behavior Therapies,Conditioning Therapies,Modification, Behavior,Technique, Behavior Change,Treatment, Behavior
D013562 Sympathectomy The removal or interruption of some part of the sympathetic nervous system for therapeutic or research purposes. Denervation, Sympathetic,Sympathetic Denervation,Denervations, Sympathetic,Sympathectomies,Sympathetic Denervations

Related Publications

J R Seibold, and N E Allegar
May 1986, The British journal of dermatology,
J R Seibold, and N E Allegar
February 1993, European heart journal,
J R Seibold, and N E Allegar
March 1993, Harefuah,
J R Seibold, and N E Allegar
January 1987, Annales de dermatologie et de venereologie,
J R Seibold, and N E Allegar
October 2008, Autoimmunity reviews,
J R Seibold, and N E Allegar
January 2009, Revista clinica espanola,
J R Seibold, and N E Allegar
October 1980, Revue medicale de Liege,
J R Seibold, and N E Allegar
November 1979, Lakartidningen,
J R Seibold, and N E Allegar
November 1976, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
J R Seibold, and N E Allegar
April 1978, Cancer treatment reports,
Copied contents to your clipboard!